Mivacurium
Back to searchMolecule Structure
Scientific Name
Mivacurium
Description of the Drug
Mivacurium is a short-acting non-depolarizing neuromuscular blocking agent used to induce anesthesia during intubation and promote skeletal muscle relaxation during surgery or mechanical ventilation.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01226
http://www.drugbank.ca/drugs/DB01226
Brand Name(s)
Not Available
Company Owner(s)
Abbvie Inc, Rising Pharma Holding Inc, Woodward Pharma Services Llc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Muscle-type nicotinic acetylcholine receptor | PROTEIN COMPLEX GROUP | ANTAGONIST | CHEMBL2362997 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL10014476 | ||
PharmGKB | PA450528 | ||
Human Metabolome Database | HMDB0015357 | ||
DrugBank | DB01226 | ||
PubChem: Thomson Pharma | 14816757 | ||
PubChem | 5281042 | ||
Nikkaji | J283.273I | ||
EPA CompTox Dashboard | DTXSID6048333 | ||
DrugCentral | 1822 | ||
Guide to Pharmacology | 7243 | ||
rxnorm | MIVACRON | MIVACURIUM | MIVACURIUM CHLORIDE |
KEGG Ligand | C07550 | ||
ChEBI | 6958 | ||
ZINC | ZINC000150338702 |